Flowonix Medical Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Flowonix Medical Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011713
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Flowonix Medical Inc (Flowonix), formerly Medasys Inc is a medical device company that designs and manufactures implantable drug pump to deliver therapeutic drugs into the spine to relieve chronic disorders. The company’s products include prometra pump, catheter, and accessories and programmer. Its accessories and programmers comprise refill kit and catheter access kit and prometra programmer. The company also develops programmable valve pumps, long life power supplies for implantable pumps, implantable and refillable pumps, low power electromagnetic valves, pump diagnostic systems, septumless implantable pumps, and others. Flowonix is headquartered in Mt Olive, New Jersey, the US.

Flowonix Medical Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Flowonix Medical Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Flowonix Medical Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Flowonix Medical Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Flowonix Medical Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Flowonix Medical Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Flowonix Medical Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Flowonix Medical Raises USD10.5 Million in Venture Financing 10
Flowonix Medical Secures USD5 Million in Venture Debt Financing 11
Flowonix Medical Raises USD20 Million in Venture Financing 12
Flowonix Medical Secures USD20 Million from Hercules Technology Growth Capital 13
Flowonix Medical Raises USD15 Million in Venture Financing 14
Flowonix Medical Raises US$25 Million In Venture Financing 15
Partnerships 16
Flowonix Medical Enters into Agreement with Cerebral Therapeutics 16
Flowonix Medical Inc – Key Competitors 17
Flowonix Medical Inc – Key Employees 18
Flowonix Medical Inc – Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Corporate Communications 20
May 18, 2016: Flowonix Medical Appoints Larry Heaton as CEO 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Flowonix Medical Inc, Medical Equipment, Key Facts 2
Flowonix Medical Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Flowonix Medical Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Flowonix Medical Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Flowonix Medical Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Flowonix Medical Inc, Deals By Market, 2011 to YTD 2017 8
Flowonix Medical Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Flowonix Medical Raises USD10.5 Million in Venture Financing 10
Flowonix Medical Secures USD5 Million in Venture Debt Financing 11
Flowonix Medical Raises USD20 Million in Venture Financing 12
Flowonix Medical Secures USD20 Million from Hercules Technology Growth Capital 13
Flowonix Medical Raises USD15 Million in Venture Financing 14
Flowonix Medical Raises US$25 Million In Venture Financing 15
Flowonix Medical Enters into Agreement with Cerebral Therapeutics 16
Flowonix Medical Inc, Key Competitors 17
Flowonix Medical Inc, Key Employees 18

★海外企業調査レポート[Flowonix Medical Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Children’s Medical Center:企業の戦略的SWOT分析
    Children's Medical Center - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Excelsior Medical Co Ltd (4104)-医療機器分野:企業M&A・提携分析
    Summary Excelsior Medical Co., Ltd. (Excelsior Medical), formerly Enfield Medical Co., Ltd. is a medical equipment manufacturer that develops and markets products for intraluminal catheter care. The company’s products include SwabCap, SwabFlush, SwabKIT, ZR syringes, flush syringes, PharmAssist and …
  • Bayer AG (BAYN):企業の財務・戦略的SWOT分析
    Bayer AG (BAYN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Stage Stores Inc:戦略・SWOT・企業財務分析
    Stage Stores Inc - Strategy, SWOT and Corporate Finance Report Summary Stage Stores Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Exonate Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Exonate Ltd (Exonate) is a biopharmaceutical company that discovers and develops small molecule drugs which modulates the alternative mRNA splicing for the treatment of unmet medical needs. The comany's alternative mRNA splicing is modulated in disease states that results in the pathological …
  • Pioneer Natural Resources Co (PXD)-石油・ガス分野:企業M&A・提携分析
    Summary Pioneer Natural Resources Company (Pioneer) is an independent oil and natural gas exploration and production company. Its principally operates in Eagle Ford Shale, Permian Basin, Raton Basin, and West Panhandle. In Permian Basin, the company carries out its exploration and production activit …
  • Amarantus Bioscience Holdings Inc (AMBS):企業の財務・戦略的SWOT分析
    Summary Amarantus Bioscience Holdings Inc (Amarantus), formerly Amarantus BioSciences Inc, is a biotechnology company that discovers and develops treatments for various therapeutic diseases. The company’s pipeline products comprise eltoprazine and mesencephalic-astrocyte-derived neurotrophic factor. …
  • Jiangsu Expressway Co Ltd (600377):企業の財務・戦略的SWOT分析
    Summary Jiangsu Expressway Co Ltd (Jiangsu Expressway) is a highway development company that offers services in investment, construction, operation and management of toll expressways within Jiangsu province. The company offers services such as geographical services, service area development, express …
  • Cutispharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary CutisPharma Inc (CutisPharma) is a pharmaceutical company that develops and distributes kits. The company offers products such as oral suspensions, suppositories, oral solutions, and topical, among others. Its oral solutions and oral suspensions include mouthwashes, anti-microbial, and PPIs; …
  • AxoGen Inc (AXGN):医療機器:M&Aディール及び事業提携情報
    Summary AxoGen Inc (AxoGen), formerly LecTec Corp is a provider of surgical solutions to measure and monitor nerve functions. The company offers products such as AxoTouch two-point discriminator, AxoGuard nerve connector, Avance nerve graft, AcroVal NSTMS and AxoGuard nerve protector products, among …
  • Siberian Coal Energy Co:企業の戦略・SWOT・財務情報
    Siberian Coal Energy Co - Strategy, SWOT and Corporate Finance Report Summary Siberian Coal Energy Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Takara Bio Inc (4974):医療機器:M&Aディール及び事業提携情報
    Summary Takara Bio Inc (Takara), a subsidiary of Takara Holdings Inc, is a biotechnology company that develops, manufactures and distributes biotechnology research reagents and equipments for life sciences research. The company sells gene amplification system and offers scientific instruments. It of …
  • NovoCure Ltd (NVCR):企業の財務・戦略的SWOT分析
    Summary NovoCure Ltd (NovoCure) is an drug company that offers development and commercialization of novel therapies for tumor treating fields. The company’s pipeline products find application in cancer indications such as malignant melanoma, hepatocellular carcinoma, ovarian cancer, breast cancer an …
  • Pennon Group Plc (PNN):企業の財務・戦略的SWOT分析
    Pennon Group Plc (PNN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • 3M Co (MMM):医療機器:M&Aディール及び事業提携情報
    Summary 3M Company (3M) is a diversified technology company that specializes in the development, manufacture and marketing of a wide range of innovative products. The company develops technology platforms, including adhesives, abrasives, light management, microreplication, non woven materials, nanot …
  • Lifetech Scientific (Shenzhen) Co Ltd:企業の製品パイプライン分析2018
    Summary Lifetech Scientific (Shenzhen) Co Ltd (Lifetech Shenzhen), a subsidiary of Lifetech Scientific Corp, is a medical device company that offers minimally invasive interventional medical devices for cardiovascular and peripheral vascular diseases. The company provides products such as dilator, o …
  • The Credit Mutuel-Cic Group
    The Credit Mutuel-Cic Group - Strategy, SWOT and Corporate Finance Report Summary The Credit Mutuel-Cic Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Newcastle University-製薬・医療分野:企業M&A・提携分析
    Summary Newcastle University (NU) is an educational university that offers teaching and research services. The university provides teaching and study services including postgraduate study, undergraduate study, and campus services. It offers teaching services in areas of accounting and finance; agri- …
  • Canadian Utilities Limited:企業の戦略・SWOT・財務分析
    Canadian Utilities Limited - Strategy, SWOT and Corporate Finance Report Summary Canadian Utilities Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Eloro Resources Ltd (ELO):企業の財務・戦略的SWOT分析
    Summary Eloro Resources Ltd (Eloro Resources) is a mining and minerals exploration and development company that offers mineral exploration and development services. The company acquires, explores and develops precious and base-metal resources properties across Quebec. It explores for titanium, silve …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆